目次

1 Report Overview
1.1 Introduction to Precision Cancer Diagnostic Test Market
1.2 Global Precision Cancer Diagnostic Test Market Overview
1.3 What Are the Objectives of this Report?
1.4 What is the Scope of the Report?
1.5 Precision Cancer Diagnostic Test Market Definition
1.6 Why You Should Read this Report
1.7 What this Report Delivers
1.8 Key Questions Answered by this Analytical Report Include:
1.9 Who is this Report for?
1.10 Research Methodology
1.10.1 Primary Research
1.10.2 Secondary Research
1.10.3 Market Evaluation & Forecasting Methodology
1.11 Frequently Asked Questions (FAQs)
1.12 Associated Visiongain Reports
1.13 About Visiongain

2 Executive Summary

3 Global Market Dynamics
3.1 Market Driving Factors
3.1.1 Emerging FPM Models and Technologies
3.1.2 NGS Technologies Are Rapidly Being Used in Place of Traditional Approaches
3.1.3 Precision Cancer Medicine's Expanding Breadth
3.2 Market Restraining Factors
3.2.1 Disadvantages and Limitations of Precision Medicine in Cancer
3.2.2 Cost of Cancer Precision Medicine
3.2.3 Difficulty of Converting Basic Genetic Data into Clinically Relevant and Effective Conclusions
3.3 Opportunities in the Global Market
3.3.1 Enhanced Trial Opportunities
3.3.2 Number of Companion Molecular Diagnostic Assays Approved by the FDA is Increasing
3.3.3 Integration of Diagnostic and Treatment Data with Emerging Artificial Intelligence/Machine Learning Platforms
3.3.4 CDx Can Play an Important Function
3.4 Challenges in the Global Market
3.4.1 Expense of Testing for Genetic Changes and Subsequent Targeted Therapy
3.4.2 Precision Medicine's Incorporation into Clinical Oncology Operations Has Been Delayed
3.4.3 Technical Difficulties Related with the Development of Precision Medicine’s Evidence
3.5 SWOT Analysis
3.6 PEST Analysis
3.6.1 Political
3.6.2 Economical
3.6.3 Social
3.6.4 Technological
3.7 Porters Analysis
3.7.1 Competitive Rivalry
3.7.2 Bargaining Power of Suppliers
3.7.3 Bargaining Power of Customers
3.7.4 Threat of New Entrants
3.7.5 Threat of Substitutes

4 Global Precision Cancer Diagnostic Test Market Analysis
4.1 Global Market Outlook
4.2 Global Market Size Estimation and Forecast
4.2.1 Pre-COVID-19 Market Scenario
4.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

5 Global Precision Cancer Diagnostic Test Market Analysis by Region
5.1 North America
5.2 Europe
5.3 Asia-Pacific
5.4 LAMEA
5.5 Regional Market Size Estimation and Forecast
5.5.1 Pre-COVID-19 Market Scenario
5.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

6 Global Market Size Estimation and Forecast by Biopsy Method
6.1 Tissue Biopsy
6.2 Liquid Biopsy
6.3 Pre-COVID-19 Market Scenario
6.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

7 Global Market Size Estimation and Forecast by End-User
7.1 Hospitals
7.2 Clinics
7.3 Research Institutes
7.4 Pre-COVID-19 Market Scenario
7.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

8 Global Market Size Estimation and Forecast by Category
8.1 Cancer Imaging
8.2 Molecular Cancer Testing
8.3 Tumour Marker Immunoassays
8.4 POC Colon Cancer Tests
8.5 Others
8.6 Pre-COVID-19 Market Scenario
8.7 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

9 Global Market Size Estimation and Forecast by Cancer Type
9.1 Breast Cancer
9.2 Lung Cancer
9.3 Colorectal Cancer
9.4 Melanoma
9.5 Pancreatic Cancer
9.6 Other Cancer Types
9.7 Pre-COVID-19 Market Scenario
9.8 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

10 Global Market Size Estimation and Forecast by Molecular Cancer Testing
10.1 Blood-Based Molecular Cancer Tests
10.2 HPV Genotyping
10.3 Circulating Tumour Cell (CTC) Tests
10.4 Next-Generation Sequencing Tests
10.5 Pre-COVID-19 Market Scenario
10.6 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

11 Global Market Size Estimation and Forecast by Cancer Imaging Test
11.1 Computed Tomography
11.2 Magnetic Resonance Imaging
11.3 Digital & Analog Mammography
11.4 Positron Emission Tomography
11.5 Digital Breast Tomosynthesis
11.6 Molecular Breast Imaging
11.7 Pre-COVID-19 Market Scenario
11.8 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

12 North America Market Size Estimation and Forecast
12.1 Market Outlook
12.2 North America Market Size Estimation and Forecast
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 Country Market Size Estimation and Forecast
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 North America Market Size Estimation and Forecast by Biopsy Method
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 North America Market Size Estimation and Forecast by End-User
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 North America Market Size Estimation and Forecast by Category
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 North America Market Size Estimation and Forecast by Cancer Type
12.7.1 Pre-COVID-19 Market Scenario
12.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 North America Market Size Estimation and Forecast by Molecular Cancer Testing
12.8.1 Pre-COVID-19 Market Scenario
12.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.9 North America Market Size Estimation and Forecast by Cancer Imaging Test
12.9.1 Pre-COVID-19 Market Scenario
12.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.10 US Precision Cancer Diagnostic Test Market Analysis
12.10.1 Increasing Number of Precision Medicine Clinical Trials in the United States
12.10.2 Pre-COVID-19 Market Scenario
12.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.11 Canada Precision Cancer Diagnostic Test Market Analysis
12.11.1 Adoption of New Systemic Cancer Medicines in Canada is a Multi-Step Process
12.11.2 The Use of Precision Medicine in Canada Will Aid in the Control of Cancer
12.11.3 Pre-COVID-19 Market Scenario
12.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.12 Mexico Precision Cancer Diagnostic Test Market Analysis
12.12.1 Developing Successful and Long-Term Precision Oncology Programmes in Mexico in Collaboration with Government Authorities and Institutions
12.12.2 Pre-COVID-19 Market Scenario
12.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

13 Europe Market Size Estimation and Forecast
13.1 Market Outlook
13.2 Europe Market Size Estimation and Forecast
13.2.1 Pre-COVID-19 Market Scenario
13.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.3 Country Market Size Estimation and Forecast
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 Europe Market Size Estimation and Forecast by Biopsy Method
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 Europe Market Size Estimation and Forecast by End-User
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 Europe Market Size Estimation and Forecast by Category
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 Europe Market Size Estimation and Forecast by Cancer Type
13.7.1 Pre-COVID-19 Market Scenario
13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 Europe Market Size Estimation and Forecast by Molecular Cancer Testing
13.8.1 Pre-COVID-19 Market Scenario
13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 Europe Market Size Estimation and Forecast by Cancer Imaging Test
13.9.1 Pre-COVID-19 Market Scenario
13.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 Germany Precision Cancer Diagnostic Test Market Analysis
13.10.1 Rapid Integration of Interdisciplinary Techniques in Germany
13.10.2 Pre-COVID-19 Market Scenario
13.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 UK Precision Cancer Diagnostic Test Market Analysis
13.11.1 Expanding Clinical Trails Studies in UK
13.11.2 Investment in Pancreatic Cancer Research
13.11.3 Pre-COVID-19 Market Scenario
13.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 France Precision Cancer Diagnostic Test Market Analysis
13.12.1 Pre-COVID-19 Market Scenario
13.12.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.13 Italy Precision Cancer Diagnostic Test Market Analysis
13.13.1 The Expansion of Precision Oncology in Italy Has Been Impeded by a Lack of Guidelines
13.13.2 Pre-COVID-19 Market Scenario
13.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.14 Spain Precision Cancer Diagnostic Test Market Analysis
13.14.1 Precision Cancer Diagnostic Test Research is Now Focusing on Detecting a Far Larger Number of Mutations in Spain
13.14.2 Pre-COVID-19 Market Scenario
13.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.15 Rest of Europe Precision Cancer Diagnostic Test Market Analysis
13.15.1 Pre-COVID-19 Market Scenario
13.15.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

14 Asia-Pacific Market Size Estimation and Forecast
14.1 Market Outlook
14.2 Asia-Pacific Market Size Estimation and Forecast
14.2.1 Pre-COVID-19 Market Scenario
14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.3 Country Market Size Estimation and Forecast
14.3.1 Pre-COVID-19 Market Scenario
14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.4 Asia-Pacific Market Size Estimation and Forecast by Biopsy Method
14.4.1 Pre-COVID-19 Market Scenario
14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.5 Asia-Pacific Market Size Estimation and Forecast by End-User
14.5.1 Pre-COVID-19 Market Scenario
14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.6 Asia-Pacific Market Size Estimation and Forecast by Category
14.6.1 Pre-COVID-19 Market Scenario
14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.7 Asia-Pacific Market Size Estimation and Forecast by Cancer Type
14.7.1 Pre-COVID-19 Market Scenario
14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.8 Asia-Pacific Market Size Estimation and Forecast by Molecular Cancer Testing
14.8.1 Pre-COVID-19 Market Scenario
14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.9 Asia-Pacific Market Size Estimation and Forecast by Cancer Imaging Test
14.9.1 Pre-COVID-19 Market Scenario
14.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.10 China Precision Cancer Diagnostic Test Market Analysis
14.10.1 Large-Scale Deployment of Self-Powered Triboelectric Nanogenerator (TENG) Devices Has Promise for Cancer Treatment
14.10.2 Pre-COVID-19 Market Scenario
14.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.11 India Precision Cancer Diagnostic Test Market Analysis
14.11.1 Pre-COVID-19 Market Scenario
14.11.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.12 Japan Precision Cancer Diagnostic Test Market Analysis
14.12.1 Precision Oncology Is Revolutionising Cancer Patient Treatment in Japan, but Many Hospitals Are Having Trouble Putting it into Practise
14.12.2 Pre-COVID-19 Market Scenario
14.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.13 South Korea Precision Cancer Diagnostic Test Market Analysis
14.13.1 Various Precision Medicine Collaborations Are Taking Place in South Korea
14.13.2 Pre-COVID-19 Market Scenario
14.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.14 Australia Precision Cancer Diagnostic Test Market Analysis
14.14.1 Pre-COVID-19 Market Scenario
14.14.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.15 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market Analysis
14.15.1 Pre-COVID-19 Market Scenario
14.15.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

15 LAMEA Market Size Estimation and Forecast
15.1 Market Outlook
15.2 LAMEA Market Size Estimation and Forecast
15.2.1 Pre-COVID-19 Market Scenario
15.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.3 Country Market Size Estimation and Forecast
15.3.1 Pre-COVID-19 Market Scenario
15.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.4 LAMEA Market Size Estimation and Forecast by Biopsy Method
15.4.1 Pre-COVID-19 Market Scenario
15.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.5 LAMEA Market Size Estimation and Forecast by End-User
15.5.1 Pre-COVID-19 Market Scenario
15.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.6 LAMEA Market Size Estimation and Forecast by Category
15.6.1 Pre-COVID-19 Market Scenario
15.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.7 LAMEA Market Size Estimation and Forecast by Cancer Type
15.7.1 Pre-COVID-19 Market Scenario
15.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.8 LAMEA Market Size Estimation and Forecast by Molecular Cancer Testing
15.8.1 Pre-COVID-19 Market Scenario
15.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.9 LAMEA Market Size Estimation and Forecast by Cancer Imaging Test
15.9.1 Pre-COVID-19 Market Scenario
15.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.10 Brazil Precision Cancer Diagnostic Test Market Analysis
15.10.1 Brazil is Making Significant Contributions to Cancer Research
15.10.2 Brazil Can Easily Become a Model for Other Latin American Countries, in Terms of the Potential Benefits of Precision Medicine
15.10.3 Pre-COVID-19 Market Scenario
15.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.11 South Africa Precision Cancer Diagnostic Test Market Analysis
15.11.1 To Develop Precision Medicine Requires More Specialised Professionals in South Africa
15.11.2 Pre-COVID-19 Market Scenario
15.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.12 Saudi Arabia Precision Cancer Diagnostic Test Market Analysis
15.12.1 Precision Cancer Diagnostic Test Has Significantly Revolutionised the Cancer Diagnostic and Treatment Environment in Saudi Arabia
15.12.2 Pre-COVID-19 Market Scenario
15.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.13 Turkey Precision Cancer Diagnostic Test Market Analysis
15.13.1 Pre-COVID-19 Market Scenario
15.13.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.14 UAE Precision Cancer Diagnostic Test Market Analysis
15.14.1 Companies in the UAE Utilising New Collaboration Strategies to Increase Precision Cancer Diagnostic Test
15.14.2 Pre-COVID-19 Market Scenario
15.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.15 Rest of LAMEA Precision Cancer Diagnostic Test Market Analysis
15.15.1 Pre-COVID-19 Market Scenario
15.15.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

16 Company Profiles
16.1 Bio-Rad Laboratories Inc.
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Company Financial Profile
16.1.4 Company Product Benchmarking
16.1.5 Company Recent Developments
16.2 Illumina Inc
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Company Financial Profile
16.2.4 Company Product Benchmarking
16.2.5 Company Recent Developments
16.3 Biocept Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Company Financial Profile
16.3.4 Company Product Benchmarking
16.3.5 Company Recent Developments
16.4 Epigenomics AG
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Company Financial Profile
16.4.4 Company Product Benchmarking
16.5 AstraZeneca plc
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Company Financial Profile
16.5.4 Company Product Benchmarking
16.5.5 Company Recent Developments
16.6 Myriad Genetics Inc.
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Company Product Benchmarking
16.6.4 Company Recent Developments
16.7 Quest Diagnostics Inc.
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Company Financial Profile
16.7.4 Company Product Benchmarking
16.7.5 Company Recent Developments
16.8 Abbott Laboratories
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Company Financial Profile
16.8.4 Company Product Benchmarking
16.8.5 Company Recent Developments
16.9 Agilent Technologies Inc.
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Company Financial Profile
16.9.4 Company Product Benchmarking
16.9.5 Company Recent Developments
16.10 Becton Dickinson and Co.
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Company Financial Profile
16.10.4 Company Product Benchmarking
16.10.5 Company Recent Developments

17 Conclusion and Recommendations
17.1 Conclusion Summary
17.2 Recommendations

List of Figures
Figure 1 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 2 Global Precision Cancer Diagnostic Test Market Segmentation
Figure 3 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 4 SWOT Analysis
Figure 5 PEST Analysis
Figure 6 Porters Five Forces
Figure 7 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 8 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 9 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 10 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 11 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 12 Global Precision Cancer Diagnostic Test Market Share Forecast by Region 2022, 2027, 2032 (%)
Figure 13 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%))
Figure 14 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 15 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 16 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 17 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 18 Global Precision Cancer Diagnostic Test Market Share Forecast by Biopsy Method 2022, 2027, 2032 (%)
Figure 19 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 20 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 21 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 22 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 23 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 24 Global Precision Cancer Diagnostic Test Market Share Forecast by End-User 2022, 2027, 2032 (%)
Figure 25 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 26 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 27 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 28 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 29 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 30 Global Precision Cancer Diagnostic Test Market Share Forecast by Category 2022, 2027, 2032 (%)
Figure 31 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 32 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 33 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 34 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 35 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 36 Global Precision Cancer Diagnostic Test Market Share Forecast by Cancer Type 2022, 2027, 2032 (%)
Figure 37 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 38 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 39 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 40 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 41 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 42 Global Precision Cancer Diagnostic Test Market Share Forecast by Molecular Cancer Testing 2022, 2027, 2032 (%)
Figure 43 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 44 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 45 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 46 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 47 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 48 Global Precision Cancer Diagnostic Test Market Share Forecast by Cancer Imaging Test 2022, 2027, 2032 (%)
Figure 49 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 50 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 51 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 52 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 53 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 54 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 55 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 56 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 57 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 58 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 59 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%))
Figure 60 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (V-Shaped Recovery Scenario)
Figure 61 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (W-Shaped Recovery Scenario)
Figure 62 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (U-Shaped Recovery Scenario)
Figure 63 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (L-Shaped Recovery Scenario)
Figure 64 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 65 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 66 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 67 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 68 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 69 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 70 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 71 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 72 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 73 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 74 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 75 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 76 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 77 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 78 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 79 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 80 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 81 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 82 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 83 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 84 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 85 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 86 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 87 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 88 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 89 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 90 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 91 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 92 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 93 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 94 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 95 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 96 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 97 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 98 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 99 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 100 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 101 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 102 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 103 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 104 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 105 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 106 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 107 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 108 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 109 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 110 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 111 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 112 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 113 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 114 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 115 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 116 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 117 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 118 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 119 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 120 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 121 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 122 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 123 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 124 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 125 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 126 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 127 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 128 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 129 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 130 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 131 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 132 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 133 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 134 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 135 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 136 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 137 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 138 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 139 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 140 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 141 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 142 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 143 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 144 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 145 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 146 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 147 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 148 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 149 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 150 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 151 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 152 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 153 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 154 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 155 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 156 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 157 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 158 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 159 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 160 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 161 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 162 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 163 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 164 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 165 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 166 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 167 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 168 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 169 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 170 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 171 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 172 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 173 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 174 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 175 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 176 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 177 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 178 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 179 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 180 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 181 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 182 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 183 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 184 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 185 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 186 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 187 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 188 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 189 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 190 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 191 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 192 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 193 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 194 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 195 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 196 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 197 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 198 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 199 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 200 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 201 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 202 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 203 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 204 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 205 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 206 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 207 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 208 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 209 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 210 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 211 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 212 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 213 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 214 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 215 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 216 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 217 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 218 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 219 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 220 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 221 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 222 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 223 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 224 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 225 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 226 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 227 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 228 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 229 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 230 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 231 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 232 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 233 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 234 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 235 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 236 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 237 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 238 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 239 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 240 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 241 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 242 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 243 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 244 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 245 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 246 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 247 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 248 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 249 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 250 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 251 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 252 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 253 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 254 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 255 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 256 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 257 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 258 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 259 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 260 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 261 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 262 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 263 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 264 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 265 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 266 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 267 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 268 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 269 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 270 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 271 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 272 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 273 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 274 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 275 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 276 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 277 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 278 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 279 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 280 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 281 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 282 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 283 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 284 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 285 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 286 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 287 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 288 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 289 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 290 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 291 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 292 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 293 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 294 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 295 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 296 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 297 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 298 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 299 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 300 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 301 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 302 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 303 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 304 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 305 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 306 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 307 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 308 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 309 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 310 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 311 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 312 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 313 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 314 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 315 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 316 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 317 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 318 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 319 Bio-Rad Laboratories Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 320 Bio-Rad Laboratories Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 321 Bio-Rad Laboratories Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 322 Illumina Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 323 Illumina Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 324 Illumina Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 325 Biocept Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 326 Biocept Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 327 Biocept Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 328 Epigenomics AG: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 329 Epigenomics AG: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 330 Epigenomics AG: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 331 AstraZeneca Plc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 332 AstraZeneca Plc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 333 AstraZeneca Plc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 334 Quest Diagnostics Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 335 Quest Diagnostics Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 336 Abbott Laboratories: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 337 Abbott Laboratories: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 338 Abbott Laboratories: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 339 Agilent Technologies Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 340 Agilent Technologies Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 341 Agilent Technologies Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 342 Becton Dickinson and Co: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 343 Becton Dickinson and Co: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 344 Becton Dickinson and Co: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)

List of Tables
Table 1 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 2 Global Precision Cancer Diagnostic Test Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 3 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 4 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 5 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (